ArticleMultiple sclerosis journal - experimental, translational and clinical

Immune cell subset profiling in multiple sclerosis after fingolimod initiation and continued treatment: The FLUENT study.

Yang Mao-Draayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.